ZyGenerics ATENOLOL Tablets — Class II drug recall D-0007-2015
Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2014-10-15, distributed nationwide. Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker
| Recall number | D-0007-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zydus Pharmaceuticals USA Inc, Pennington, NJ, United States |
| Recall initiated | 2014-08-05 |
| Classified | 2014-10-03 |
| Reported by FDA | 2014-10-15 |
| Terminated | 2017-09-22 |
| Distributed | Nationwide (US) |
| Quantity | 5,400 bottles |
| Reason classes | potency |
| NDC | 68382-0022, 68382-0022-01, 68382-0022-10, 68382-0022-16, 68382-0022-24, 68382-0022-40, 68382-0023, 68382-0023-01, 68382-0023-02, 68382-0023-10, 68382-0023-16, 68382-0023-24, 68382-0023-40, 68382-0024, 68382-0024-01, 68382-0024-10, 68382-0024-16, 68382-0024-40 |
Product
ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08634 USA NDC 68382-022-01
Reason for recall
Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets were noticeably thicker in appearance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0007-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.